Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 83 EEO4 | DOI: 10.1530/endoabs.83.EEO4

EYES2022 ESE Young Endocrinologists and Scientists (EYES) 2022 Environmental Endocrinology (4 abstracts)

Impact of COVID-19 on women’s reproductive health

Saravinovska K1, Marina Lj.1, 2, Dugić B3, Petković D1, Šojat A. S.2, Rosić N1, Petković T2, Antić N2, Ristović N1, Ivović M.1, 2, Tančić-Gajić M.1, 2, Arizanović Z2 & Vujović S.1, 2


1University of Belgrade, Faculty of Medicine; 2 Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, National Centre for Infertility and Endocrinology of Gender; 3 University of Belgrade, School of Electrical Engineering


Background: Reproductive health is an integral part of a women’s general health and is influenced by various endogenous and exogenous factors.

Objectives: The aim was to detect the possible effects of COVID-19 on women’s reproductive health.

Methods: We created an anonymous survey about reproductive health and shared it with women of reproductive age. Regarding menstrual cycle characteristics all women used the smartphone application for period tracking.

Results: 205 women completed the survey. Based on inclusion, exclusion and complete data availability 162 surveys were taken into the final analysis. Mean age was 28.8 ± 9.5 years. 115 (71%) women reported previously being infected with COVID-19. 94 (81.7%) of these women reported having changes in their menstrual cycle (MC) afterwards (P < 0.0001) when compared to non-COVID19 participants. Women under the age of 30 who had a COVID-19 were more likely to have changes in their MC (P = 0.02) when compared to women older than 30. 42 (36.5%) women reported having heavier periods (P < 0.0001), 22 (19.1%) reported earlier periods (P = 0.04) and 23 (20%) women reported more pronounced premenstrual symptoms (P = 0.015). 62 (54%) women reported gaining weight during the pandemic, with a median of 4 kg. The main specific stressor was a difficulty accessing healthcare (30/26%) (P = 0.035). The age was the most significant predictor of changes in the MC (B=0.054, 95% CI B=1.004 - 1.109, P = 0.034).

Conclusions: According to our data COVID-19 leads to MC changes, especially in women under 30, such as heavier periods, shorter duration of MC and worsening of PMS. Other possible consequences remain yet to be elucidated.

Volume 83

ESE Young Endocrinologists and Scientists (EYES) 2022

Zagreb, Croatia
02 Sep 2022 - 04 Sep 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.